374 filings
Page 9 of 19
8-K
NRXP
NRX Pharmaceuticals Inc
11 Feb 22
Departure of Directors or Certain Officers
9:01am
8-K
NRXP
NRX Pharmaceuticals Inc
3 Feb 22
NRx Pharmaceuticals Announces Closing of $25 Million Private Placement Priced at a Premium to Market under Nasdaq Rules
6:07am
424B3
NRXP
NRX Pharmaceuticals Inc
18 Nov 21
Prospectus supplement
4:05pm
424B3
NRXP
NRX Pharmaceuticals Inc
18 Nov 21
Prospectus supplement
4:01pm
10-Q
2021 Q3
NRXP
NRX Pharmaceuticals Inc
Quarterly report
15 Nov 21
4:03pm
4
Herbert Raymond McMaster
2 Nov 21
NRX Pharmaceuticals / Herbert Raymond McMaster ownership change
4:07pm
4
Daniel C. Javitt
2 Nov 21
NRX Pharmaceuticals / Daniel C. Javitt ownership change
4:06pm
4
Alessandra Daigneault
2 Nov 21
NRX Pharmaceuticals / Alessandra Daigneault ownership change
4:05pm
4
NRXP
NRX Pharmaceuticals Inc
2 Nov 21
NRX Pharmaceuticals / Robert Besthof ownership change
4:04pm
3
Herbert Raymond McMaster
2 Nov 21
NRX Pharmaceuticals / Herbert Raymond McMaster ownership change
4:03pm
SC 13D/A
NRXP
NRX Pharmaceuticals Inc
2 Nov 21
NRX Pharmaceuticals / Javitt Jonathan C ownership change
4:02pm
424B3
NRXP
NRX Pharmaceuticals Inc
21 Oct 21
Prospectus supplement
4:18pm
424B3
NRXP
NRX Pharmaceuticals Inc
21 Oct 21
Prospectus supplement
4:18pm
8-K
NRXP
NRX Pharmaceuticals Inc
21 Oct 21
Entry into a Material Definitive Agreement
4:17pm
424B3
NRXP
NRX Pharmaceuticals Inc
15 Oct 21
Prospectus supplement
12:00am
424B3
NRXP
NRX Pharmaceuticals Inc
15 Oct 21
Prospectus supplement
12:00am
8-K
NRXP
NRX Pharmaceuticals Inc
13 Oct 21
Other Events
8:34am
EFFECT
NRXP
NRX Pharmaceuticals Inc
16 Sep 21
Notice of effectiveness
12:15am
424B3
NRXP
NRX Pharmaceuticals Inc
15 Sep 21
Prospectus supplement
4:40pm
CORRESP
NRXP
NRX Pharmaceuticals Inc
13 Sep 21
Correspondence with SEC
12:00am